Hydreight Technologies Inc (NURS)

Currency in CAD
3.20
+0.06(+1.91%)
Closed·
NURS is not included in our AI-picked strategies. See which stocks are.
Fair Value
Day's Range
2.953.24
52 wk Range
2.385.59
Key Statistics
Prev. Close
3.2
Open
3.05
Day's Range
2.95-3.24
52 wk Range
2.38-5.59
Volume
45.06K
Average Volume (3m)
98.6K
1-Year Change
-26.9406%
Book Value / Share
0.74
Fair Value
unlockUnlock
Fair Value Upside
unlockUnlock
NURS Scorecardpro icon
Company’s Health
Unlock
Fair Value
Unlock Price
Fair Price
Upside
Price Target
7.92
Upside
+147.40%
Members' Sentiments
Bearish
Bullish
ProTips
Analysts anticipate sales growth in the current year

Hydreight Technologies Inc News & Analysis

Show more

Technical Analysis

Summary
Strong Sell
Sell
Neutral
Buy
Strong Buy
Strong Buy
Technical Indicators
Strong Buy
Moving Averages
Buy

Analyst Ratings

3 Buy
0 Hold
0 Sell
Ratings:
3 analysts
Overall Consensus
Buy

Analysts 12-Month Price Target:

Average 7.92
(+147.40% Upside)
Firm
ArticlePositionPrice TargetUpside / DownsideFrom Price TargetActionDate
Canaccord
Buy6.75+110.94%8.25MaintainSep 02, 2026
Canaccord
Buy8.25+157.81%8.00MaintainJun 03, 2026

Hydreight Technologies Inc Earnings Call Summary for Q2/2026

  • Hydreight Q2 2026 revenue surged 420% YoY to CAD 28M but missed estimates ($27.39M vs $30.93M expected); shares plunged 15.7% to $3.49
  • Adjusted EPS of $0.0499 fell short of $0.0549 consensus; gross margin compressed to 19.4% from 36% YoY due to lower-margin pharmacy sales mix
  • Company maintained profitability with CAD 3.2M adjusted EBITDA (11.5% margin) and CAD 2.5M net income despite rapid scaling efforts
  • Management reaffirmed FY2026 guidance of CAD 150M revenue and 15-17% EBITDA margin, requiring significantly stronger H2 performance
  • Working capital rose to CAD 35.1M from CAD 15.7M, deployed for pharmacy partnerships and peptide product launches pending FDA approvals
Last Updated: 2026-09-01, 09:44 a/m
Read Full Transcript

Earnings

Latest Release
Sep 01, 2026
EPS / Forecast
0.05 / 0.05
Revenue / Forecast
30.16M / 30.93M
EPS Revisions
Last 90 days

NURS Income Statement

Compare NURS to Peers and Sector

Metrics to compare
NURS
Peers
Sector
Relationship
P/E Ratio
25.5x−0.6x−0.4x
PEG Ratio
0.000.000.00
Price/Book
4.4x1.0x2.6x
Price / LTM Sales
2.2x1.8x3.1x
Upside (Analyst Target)
147.4%57.0%57.4%
Fair Value Upside
Unlock17.3%7.7%Unlock

Hydreight Technologies Inc. operates in the digital health technology sector in the United States. The company develops a proprietary telemedicine service that allows users to book confidential health and wellness, and/or medical services through a mobile application. It also provides consulting and advice in setting up health and wellness services, including assistance with finding experienced advisors in the areas of medical and privacy law, among others; medical liability insurance; pharmaceutical IV programs vetted by duly licensed pharmacists; procedural guides with respect to various services, such as a range of IV therapy treatments, GLP1, NAD, Botox, and fillers; and hiring, on-boarding, training, marketing, branding, payroll, and other accounting services. In addition, the company offers an online pharmacy, which allows its network of medical practitioners to purchase pharmacy products from federally regulated pharmacies. Hydreight Technologies Inc. is headquartered in Las Vegas, Nevada.

Ownership

Ownership Overview

Type
Common Stock Held% of Shares OutstandingMarket Value
Mutual Funds & ETFs
766.54K1.43%2.45M
Other Institutional Investors
25.33M47.19%81.04M
Public Companies & Retail Investors
27.58M51.38%88.25M
Total
53.67M100.00%171.75M

Top Holders

Holder
% of holding
Shares Held
Date Reported
Value (In 1,000s)
Victory Square Technologies Inc.47.19%25,326,12481,044
Spartan Fund Management Inc.1.31%704,2002,253

People Also Watch

2.050
CCLD
-0.49%
12.85
PURR
-8.80%
1,529.80
ASML
+0.47%
0.42
PCRX
0.00%

FAQ

What Is the Hydreight Tech (NURS) Stock Price Today?

The Hydreight Tech stock price today is 3.20 CAD.

What Stock Exchange Does Hydreight Tech Trade On?

Hydreight Tech is listed and trades on the TSX Venture Exchange.

What Is the Stock Symbol for Hydreight Tech?

The stock symbol for Hydreight Tech is "NURS."

What Is the Hydreight Tech Market Cap?

As of today, Hydreight Tech market cap is 171.75M CAD.

What Is Hydreight Tech's Earnings Per Share (TTM)?

The Hydreight Tech EPS (TTM) is 0.13.

When Is the Next Hydreight Tech Earnings Date?

Hydreight Tech will release its next earnings report on Dec 02, 2026.

From a Technical Analysis Perspective, Is NURS a Buy or Sell?

Based on moving averages and other technical indicators, the daily buy/sell signal is Strong Sell.

How Many Times Has Hydreight Tech Stock Split?

Hydreight Tech has split 2 times.

What is the current trading status of Hydreight Tech (NURS)?

As of Sep 28, 2026, Hydreight Tech (NURS) is trading at a price of 3.20 CAD, with a previous close of 3.20 CAD. The stock has fluctuated within a day range of 2.95 CAD to 3.24 CAD, while its 52-week range spans from 2.38 CAD to 5.59 CAD.

What Is Hydreight Tech (NURS) Price Target According to Analysts?

The average 12-month price target for Hydreight Tech is 7.92 CAD, with a high estimate of 9 CAD and a low estimate of 6.75 CAD. 3 analysts recommend buying the stock, while 0 suggest selling, leading to an overall rating of Buy. The stock has an +147.40% Upside potential.
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2026 - Fusion Media Limited. All Rights Reserved.